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Multiple protein kinases affect the responses of dorsal horn neurons through phosphorylation of synaptic receptors
and proteins involved in intracellular signal transduction pathways, and the consequences of this modulation may
be spinal central sensitization. In contrast, the phosphatases catalyze an opposing reaction of de-phosphorylation,
which may also modulate the functions of crucial proteins in signaling nociception. This is an important
mechanism in the regulation of intracellular signal transduction pathways in nociceptive neurons. Accumulated
evidence has shown that phosphatase 2A (PP2A), a serine/threonine specific phosphatase, is implicated in synaptic
plasticity of the central nervous system and central sensitization of nociception. Therefore, targeting protein
phosphotase 2A may provide an effective and novel strategy for the treatment of clinical pain. This review will
characterize the structure and functional regulation of neuronal PP2A and bring together recent advances on the
modulation of PP2A in targeted downstream substrates and relevant multiple nociceptive signaling molecules.Introduction
Intracellular signal transduction pathways play a pivotal
role in the maintenance of biological processes such as
cell growth, proliferation, survival, and metabolism in all
cells and tissues. It has been demonstrated that a variety
of intracellular signal transduction pathways are involved
in the physiological or patho-physiological responses to
noxious stimuli [1-3]. The opposing reactions of phos-
phorylation and de-phosphorylation of critical cellular
proteins are decisive to such pathways [4,5]. Protein ki-
nases and phosphatases catalyze protein phosphorylation
and de-phosphorylation reactions, respectively. While in
the past, much attention has been paid to the regulation
of protein kinases, it is now apparent that protein phos-
phatases are highly regulated enzymes that play an equally
important role in the control of protein phosphorylation.
Accumulated evidence has shown that protein kinases are
widely implicated in pain modulation. Several protein
kinases affect the responses of spinal cord dorsal horn
neurons through phosphorylation of synaptic receptors
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reproduction in any medium, provided the orpathways, and the consequences of this modulation can
regulate the process of central sensitization [2,6-10]. How-
ever, much less is known about the role of their coun-
terparts, protein phosphatases, in nociception. Recent
studies have provided evidence that the a member of pro-
tein phosphatase family, protein phosphatase 2A (PP2A),
is involved in synaptic plasticity in the central nervous sys-
tem (CNS) or central sensitization of pain, suggesting a
new promising molecular target for pain control [11-15].
Serine/threonine specific phosphatase is one of ma-
jor classes of protein phosphatases that catalyse the
de-phosphorylation of serine and threonine residues.
According to their biological characteristics, sensitivities
to specific inhibitors and substrates, serine/threonine spe-
cific phosphatase can be divided into four major subtypes,
PP1, PP2A, PP2B and PP2C [16]. Among this family
members, PP2C belongs to a separate gene family since it
has a distinct structure from the others, whereas PP1,
PP2A and PP2B have similar primary amino acid se-
quences. There are other serine/threonine phosphatases
identified as well, including PP4, PP5, PP6 and PP7. Un-
like PP1 and PP2A, the in vitro basic activities of PP4,
PP5, PP6, and PP7 are extremely low. Of these subtypes,
PP2A is the most abundant serine/threonine protein
phosphatase in mammalian cells and is expressed at
higher levels in the CNS [17]. This review will characterize
the structure and functional regulations of PP2A andtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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de-phosphorylation of specific downstream substrates and
nociceptive signal processing.
The structure and localization of PP2A
PP2A is a major serine/threonine protein phosphatase in
mammalian cells and has been implicated in the control
of numerous biological processes including develop-
ment, cell growth, differentiation, and apoptosis. It ac-
counts for up to 1% of all cellular proteins and, together
with PP1, accounts for 90% of all serine/threonine phos-
phatase activity in most tissues and cells [18]. It predom-
inantly exists in cells as a heterotrimetic holoenzyme,
which consists of a 36 kDa catalytic subunit (PP2A-C), a
65 kDa structural subunit (PP2A-A) forming a core en-
zyme, and a variable regulatory subunit (PP2A-B), as
illustrated in Figure 1 [19]. The A structure subunit re-
cruits the C catalytic subunit to form the core dimer,
which acts as a scaffold for B subunits of the enzyme.
Four B subunit families have been identified (PR55 or B,
PR61 or B’, PR72/130 or B” and PR93/PR110 or B”’). Dif-
ferent B subunits interact via the same or overlapping
sites within the A subunit of the core dimer. The as-
sociation of these B subunits with the core AC dimer isFigure 1 Structure of protein phosphatase 2A holoenzymes. A
is the structural subunit and scaffolding protein, and C is the
catalytic subunit. B/B’/B”/B”’ are the variable and regulatory subunits.
PP2A predominantly exists in cells as a heterotrimetic holoenzyme,
which consists of a 36 kDa catalytic subunit (PP2A-C), a 65kDa
structural subunit (PP2A-A) forming a core enzyme, and a variable
regulatory subunit (PP2A-B). The A structure subunit recruits the C
catalytic subunit to form the core dimer, which acts as a scaffold for
the C and B subunits of the enzyme. Four B subunit families
including PR55or B, PR61 or B’, PR72/130 or B” and PR93/PR110 or B”’
interact via the same or overlapping sites within the A subunit of
the core dimer. The PP2A holoenzyme's substrate specificity,
enzymatic activity, and/or cellular localization can be modulated by
the B regulatory subunit.mutually exclusive. The PP2A holoenzyme's substrate
specificity, enzymatic activity, and/or cellular localization
can be modulated by the B regulatory subunit [20-23].
Each family of B subunits contains several isoforms
that can bind the AC dimer in a mutually exclusive
manner [24]. In mammalian cells, B or PR55 family (α,
β, γ and δ) is expressed in a tissue-specific manner.
PR55α and PR55δ are widely-distributed in different tis-
sues, whereas PR55β and PR55γ are highly enriched in
the brain. PR55α is distributed primarily in the cell body
and nucleus of Purkinje cells, whereas PR55β is excluded
from the nucleus and extends into dendrites. The B’
family consists of five primary members of the PR61
(α, β, γ, δ and ε) that are mapped to the human chro-
mosomes loci 1q41, 11q12, 3p21, 6p21.1, and 7p11.2,
respectively. PR61α, PR61β and PR61ε localize to the cyto-
plasm, whereas PR61γ1, PR61γ2, PR61γ3 are concentrated
in the nucleus, and PR61δ is found in both the nucleus
and the cytoplasma. PR61α and PR61γ1-γ3 are enriched in
heart and skeletal muscles. PR61β and PR61δ are expressed
predominantly in the brain. For the B” family, PR72 is
expressed exclusively in the heart and skeletal muscles,
whereas PR130 is expressed predominately in the heart
and muscles. The PR93/PR110 comprises the B”’ family.
PR110 is localized to the post-synaptic densities of neur-
onal dendrites, whereas PR93 is nuclear located (Table 1)
[16,22]. The spinal cord dorsal horn is an important area
containing sensory neurons that has been implicated in
major pain processing. Our previous immunofluorescent
staining studies have shown that the neurons with PP2A
expression are mainly distributed in the superficial layers
of the dorsal horn, laminae I and II, and a few of the PP2A
immunoreactive neurons are found in the ventral horn of
the spinal cord as well (unpublished data).
The functional regulation of PP2A activity through
post-translational modification
Previous studies have demonstrated that modulations of
PP2A activity are due to the tyrosine or serine/threonine
phosphorylation of not only the catalytic C subunit, but
also the regulatory B subunit, especially those of the B’
family [18,20]. The regulatory B subunits play key roles
in controlling PP2A substrate specificity, cellular loca-
lization, and enzymatic activity [25]. Tyrosine kinases
such as Src kinase, inhibit PP2A activity, and the PP2A
assembly can be inhibited by the phosphorylation of the
B56 subunit by extracellular signaling regulated kinase
(ERK) [26,27]. Another post-translational modification
of the catalytic C subunit, methylation, which occurs on
the carboxy group of the C-terminal residue Leu309, is
also involved in the alterations of PP2A’s activity [28,29]. It
has been shown that the methylation of PP2A-C may
influence the affinity of the AC core dimer to the different
B subunits [30,31]. For example, some B regulatory
Table 1 Tissue distribution and subcellular localization of PP2A subunits
Subunits Molecule KDa Isoforms Tissue distribution Subcellular localization
Structure subunit A 65 α and β Ubiquitously expressed
Catalytic subunit C 36 α and β Ubiquitously expressed. High levels in brain and heart.
Regulatory subunit B 55 B α Wide-spread tissue distribution Cytosolic fraction
B β Enriched in brain Cytosolic fraction
B δ Wide-spread tissue distribution
B γ Enriched in brain Cytoskeletal fraction
B’ α Widely expressed and abundant in heart and skeletal
muscle
Cytoplasma
B’ β Enriched in brain Cytoplasma
B’ δ Enriched in brain Neucleus and cytoplasma
B’ γ Widely expressed and abundant in heart and skeletal
muscle
Neucleus
B’ ε Cytoplasma
B” PR72 Heart and skeletal muscle
B”PR130 Ubiquitously expressed and high levels in heart and
muscle
B”PR59 Testis, kidney, liver, brain, heart and lung
B”PR48 neucleus
B”’ PR93 neucleus
B”’PR110 Postsynaptic densities of neuronal
dendrites
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when the catalytic C subunit has been methylated,
whereas other B subunits prefer to bind an AC dimer with
a demethylated C subunit [32]. The post-translational
modification of PP2A has been implicated in the patho-
genesis of Alzheimer’s disease (AD), a neurodegenerative
disorder with impaired synaptic plasticity [33-37]. The re-
duced methylation of PP2A C subunit at Leu309 and the
increased phosphorylation of PP2A C subunit at Tyr307
may result in loss of enzymatic activity and tau hyper-
phosphorylation in Alzheimer’s disease, indicating that
PP2A is a putative target of therapeutic intervention [34].
How the post-translational modification of PP2A is regu-
lated during nociception is still unclear and deserves fur-
ther investigations.
Substrate molecules and signal transduction cascades
regulated by PP2A in synaptic plasticity and central
sensitization in response to nociceptive stimuli
It has been demonstrated that synaptic glutamate recep-
tors play a critical role in synaptic plasticity, electro-
physiologically characterized by long term potentiation
(LTP) and long-term depression (LTD), in the central ner-
vous system [38-41]. Previous studies from ours and other
groups have demonstrated that central sensitization of
pain may represent a spinal form of LTP, since there are
close parallels in mechanisms important for LTP and cen-
tral sensitization [1,38-40] . The functional activation ofpost-synaptic glutamate receptors may influence a variety
of intracellular signals, which may trigger cellular and
molecular changes at transcriptional, translational, or
post-translational levels. Theses changes contribute to the
synaptic plasticity and central sensitization induced by
peripheral noxious stimulation [3,6,42,43]. The phosphor-
ylation and de-phosphorylation of synaptic glutamate re-
ceptors are important post-translational mechanisms in
the modulation of synaptic strength. Strong noxious
stimulation in the periphery may activate several protein
kinases such as calcium/camodulin dependent protein
kinase II (CaMKII), cAMP-dependent protein kinase
(PKA), protein kinase C (PKC), and protein kinase G
(PKG), which play an important role in the phosphoryl-
ation of glutamate receptors in spinal nociceptive neurons
[1,3,7,42-45]. The increased sensitivity of glutamate recep-
tors through the phosphorylation regulated by protein
kinases may contribute to the enhanced responsiveness of
dorsal horn neurons during central sensitization [1,3,10].
In contrast, the protein phosphotase, PP2A may reverse
these signals through the de-phosphorylation of glutamate
receptors and several intracellular protein kinases, and
therefore, blunt the central sensitization of pain [11-14].
PP2A is involved in the induction and maintenance of
synaptic plasticity: electrophysiological evidence
The modification of protein phosphorylation is a critical
element leading to the induction of synaptic plasticity.
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increased glutamate receptor phosphorylation through
various protein kinases and a concomitant decrease in pro-
tein phosphatase activity [46]. In contrast, a decrease in
synaptic strength, LTD, has been shown to be dependent
on glutamate receptor de-phosphorylation mediated by an
increase in the activity of protein phosphatases, possibly
PP1 and PP2A [47]. Thus, a coordination of kinase and
phosphatase activities is crucial for the comprehensive
modulation of synaptic plasticity.
The application of the PP1/PP2A inhibitor calyculin
A, or the post-synaptic injection of microcystin, in hip-
pocampal slices induces a rapid enhancement of synaptic
transmission , particularly in the hippocampal tissue from
aged rats [48]. It indicates that synaptic transmission can
be actively and persistently regulated by protein phospha-
tases. It has been shown that PKA plays an important role
in N-methyl-D-aspartic acid (NMDA) receptor-mediated
plasticity in the hippocampus and spinal cord through the
phosphorylation of GluN1 subunit of NMDA receptors.
Both pharmacological and genetic inhibition of the
cAMP/PKA cascade may inhibit the LTP in the hippo-
campal CA1 area [49,50]. The sensitivity of LTP (elicited
by either multiple 100-Hz trains or prolonged 5-Hz stimu-
lation) to PKA inhibition was eliminated by the prior in-
cubation of hippocampal slices with a PP1/PP2A inhibitor,
suggesting that the PKA pathway participates in LTP,
which may include the activity-dependent suppression of
PP1/PP2A activity [51,52]. It has been noted that the in-
duction of LTP is associated with an inhibition of PP2A.
The inhibition of PP2A activity was not only observed im-
mediately after the induction of LTP, but was still detect-
able one hour after induction, indicating that persistently
decreased PP2A activity may have a role in the mainten-
ance of LTP [53,54]. Furthermore, the observed inhibition
of PP2A showed a pattern of NMDA-receptors depend-
ence. The auto-phosphorylation of CaMKII triggered by
the activation of NMDA receptors is a cellular event crit-
ical to the induction of LTP. It is shown that the purified
PP2A Bα is a substrate for CaMKII phosphorylation, and
this subunit is phosphorylated during the induction of
LTP in the hippocampus [54]. Combined with these data,
we may suggest that the inhibited activity of PP2A during
LTP is associated with the phosphorylation of PP2A me-
diated by CaMKII triggered by the activation of NMDA
receptor. As for the decrease in PP2A activity, this phos-
phorylation persisted for more than one hour after LTP
induction. In view of this CaMKII-dependent decrease in
PP2A activity, it is interesting that auto-phosphorylated
CaMKII is much more readily de-phosphorylated by PP1
than by PP2A [54]. Thus, the CaMKII-dependent sup-
pression of PP2A activity and prevention of the de-
phosphorylation of CaMKII by PP2A might serve as key
processing events necessary for the LTP maintenance(Figure 2). Pi et al. [55] showed that the coupled PP2A
and CaMKII switches lead to a tristable system in which
the kinase activity is high in the LTP state, the PP2A activ-
ity is high in the LTD state, and neither activity is high in
the basal state. These data provide an explanation for
the inhibition of PP2A prevents LTD induction.
The auto-phosphorylation of CaMKII induced by teta-
nization is reported to be blocked by a PKA inhibitor, in-
dicating a potential downstream substrate regulated by
the PKA-dependent suppression of phosphatase activity.
One possibility is that PP2A regulates LTP by competing
with PKA for the regulation of specific phosphorylation
sites, such as the GluN1 subunit of NMDA receptors.
Although much more work needs to be done in this
area, the data indicate an important involvement of the
persistent down-regulation of PP2A activity in the main-
tenance of LTP. PP2A are also found to be involved in
the development of LTD in the hippocampus. A number
of studies showed that PP2A inhibitors disrupt NMDA
receptor-dependent LTD at glutamatergic synapses in
hippocampus [56,57].
PP2A is implicated in synaptic plasticity and pain central
sensitization through regulating the function of NMDA
receptors
NMDA receptors are nonselective cation channels crit-
ical for neuronal excitability and particularly for Ca2
+-dependent modulation of synaptic plasticity in noci-
ceptive processing. It was found that in the mouse nu-
cleus accumbens, endogenous PP2A regulates NMDA
receptor channel phosphorylation, activity and kinetics.
In cultured hippocampal neurons, exogenous PP2A de-
pressed the open probability of NMDA receptors [58].
Phosphatase may participate in the long-term changes in
NMDA receptor function, such as LTP or LTD. Okadaic
acid, which serves as a potent and specific inhibitor of
the serine/threonine protein phosphatases 1 and 2A,
may enhance the open probability of NMDA receptors
[59,60]. It has been demonstrated that okadaic acid
increases the NMDA and AMPA-kainate receptors-
mediated currents in neurons of the hippocampus [61].
Intra-hippocampal micro-injection of okadaic acid in-
duces the hyper-phosphorylation of the GluN2B subunit
of the NMDA receptors [62]. Association of PP2A with
NMDA receptors may result in an increase in the phos-
phatase activity of PP2A and the dephosphorylation of
Serine897 of the NMDA receptor subunit NR1. On the
other hand, the dissociation of PP2A from the complex
and the reduction of PP2A activity can be caused by
stimulation of NMDA receptors [63].
Using an animal model of inflammatory pain, our previ-
ous studies have demonstrated that PP2A plays a critical
role in determining the excitability of nociceptive neurons
in the spinal cord by modulating the phosphorylation state
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Figure 2 Molecular substrates regulated by PP2A in synaptic plasticity and central sensitization of pain. The auto-phosphorylation of
CaMKII triggered by the activation of NMDA receptors is an event critical to the induction of LTP. PP2A is a substrate for CaMKII phosphorylation
and the phosphorylated PP2A may decrease the activity of PP2A during LTP. The CaMKII-dependent suppression of PP2A activity and prevention
of the de-phosphorylation of CaMKII by PP2A may be necessary for the LTP maintenance. PP2A regulates LTP by competing with PKA for the
regulation of specific phosphorylation sites, such as the GluN1 subunits of NMDA receptors. AMPA receptor GluA1 subunit has the two major
phosphorylation sites: Ser845, which is phosporylated by PKA, and Ser 831, which is phosphorylated by PKC. CaMKII was also found to
phosphorylate both Ser831 and Ser845 in GluA1, and contributes to the single-channel conductance of the receptor, and thus, possibly increases
AMPA receptor conductance during LTP. The de-phosphorylation of Ser845 was blocked by the pretreatment with okadaic acid, indicating an
involvement of PP1 and/or PP2A. The phosphorylation or de-phosphorylation of AMPA receptors is closely associated with the receptor
trafficking. The GluA1 subunit is the important substrate of PP2A, indicating PP2A activity is a critical for AMPA receptor trafficking and might play
an important role in AMPA receptor-mediated nociception. The transcription factor cAMP-response-element-binding protein (CREB) has been
demonstrated to be involved in synaptic plasticity and gene transcription and PP2A is thought to be the main CREB phosphatase. Histone
deacetylase (HDAC) may reverse the action of histone acetylase and block the gene transcription process through the chromatin remodeling.
PP2A is responsible for the de-phosphorylation of class II HDACs and for the subsequent triggering nuclear localization and repression of target
genes, while the phosphorylaton-triggering cytoplasmatic localization may lead to the activation of target genes.
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inhibitor of PP2A, okadaic acid (OA), and a specific
inhibitor, fostriecin into the subarachnoid space may
significantly enhance the secondary mechanical hyper-
algesia and allodynia following intradermal injection of
capsaicin [14]. Further, we found that the up-regulated
phosphorylation of both GluN1 and GluN2B subunits
of NMDA receptors induced by capsaicin injection was
significantly potentiated by the PP2A inhibitor withoutaffecting the GluN1 and GluN2B protein itself in the
spinal cord dorsal horns. It suggests that PP2A may
have a regulatory effect on central sensitization induced
by noxious stimuli in the periphery by regulating the
phosphorylation state of NMDA receptors [13]. Using
an in vivo electrophysiological recording technique, our
previous study has also shown that PP2A inhibitors sig-
nificantly prolonged the responses of dorsal horn neurons
to mechanical stimuli in anesthetized rats following intra-
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volved in determining the duration of capsaicin-induced
central sensitization [11,12].
PP2A regulates the function of AMPA receptor through
influencing the dephosphorylation and trafficking of
AMPA receptor subunits
AMPA receptor has an important role in synaptic plasti-
city and central sensitization of pain [8,9,64-66]. AMPA
receptors present unique functional regulations, such as
subunits phosphorylation and membrane insertion or
internalization. The intracellular C-terminal domains of
AMPA receptor subunits allow subunit-specific regulation
by phosphorylation. There are several protein phosphoryl-
ation sites located on the C-terminal region, which are
working targets of PKA, PKC, and CaMKII [1,7]. Site-
directed mutagenesis and phosphopeptide analysis identi-
fied two major phosphorylation sites on GluR1: Ser845,
which is phosporylated by PKA, and Ser 831, which is
phosphorylated by PKC. The phosphorylation of Ser845 in
GluA1 by PKA regulates the open-channel probability of
AMPA receptors; whereas the phosphorylation of Ser831
by PKC changes channel conductance. CaMKII was also
found to phosphorylate both Ser831 and Ser845 in GluA1
and contributes to the single-channel conductance of the
receptor and possibly increases AMPA receptor con-
ductance during LTP [65]. The phosphorylation of
GluA2 plays an important role in the receptor clusters
during synaptic plasticity and persistent painful stimu-
lation [67]. It has been demonstrated that GluA2 may
be phosphorylated on Ser880 by PKC in vitro and in
transfected cells [68].
The development of phosphorylation-site-specific anti-
bodies has greatly facilitated the study of the phosphoryl-
ation state of endogenous proteins regulated by kinases
and phosphatases. Huganir’s group has shown that the
induction of LTD by prolonged, low-frequency stimulation
led to a decrease in the phosphorylation of Ser845 but not
Ser831 of GluA1 subunits, as assessed by the Western
blot analysis of hippocampal slices after stimulation [69].
The de-phosphorylation of Ser845 was blocked by pre-
treatment with okadaic acid, indicating an involvement of
PP1 and/or PP2A (Figure 2). So, GluA1 is a critical sub-
strate of protein phosphatases in LTD. Although a similar
decrease in Ser845 phosphorylation was observed when
LTD was induced chemically by the application of NMDA,
this de-phosphorylation was not blocked by high concen-
trations of either okadaic acid or calyculin A [70]. This re-
sult indicates that different populations of GluA1 might
be regulated by distinct phosphatases. Consistent with this
idea, Strack and colleagues have observed a similar phe-
nomenon in the case of another substrate, CaMKII.
Whereas soluble CaMKIIα is a PP2A substrate, transloca-
tion of CaMKIIα to the postsynaptic density by auto-phosphorylation converts it to a PP1 substrate [54]. Inter-
estingly, it is noted that CaMKII activity in the postsynap-
tic density does not appear to correlate with synaptic
insertion of GluA1 at C fiber synapses in inflammatory
pain [41,71]. Thus, this strongly supports the notion that,
even if PP1 is the major phosphatase in the postsynaptic
density, cytosolic PP2A (or PP2B) may regulate the auto-
phosphorylation of CaMKII that mediates synaptic AMPA
receptor incorporation. However, the synaptic induction
of LTD is associated with the de-phosphorylation of
Ser845, but not Ser831, and the induction of LTP in naive
slices is observed to be associated with an increase in the
phosphorylation of Ser831, but not Ser845. LTP-inducing
stimulation only elicited increased Ser845 phosphorylation
when LTP was induced at previously depressed synapses.
Conversely, at previously potentiated synapses, the ad-
ministration of de-potentiating, low-frequency stimuli
produced de-phosphorylation of Ser831, but not Ser845
[69,72,73]. These studies show that the de-phosphorylation
regulation by protein phosphotases in synaptic plasticity is
associated with the functional status of the synapses. In
spinal neurons, our group has shown that PKA mediates
the phosphorylation of serine at the Ser845 site, and PKC
targets the Ser831 site following noxious stimulation [7].
Further, we have demonstrated that AMPA receptors
showed enhanced responsiveness to nociceptive stimula-
tion through this phosphorylation step during central
sensitization [1]. However, much less is known about the
de-phosphorylation regulation of GluA1 or GluA2 sub-
units by PP2A in different pain models.
The de-phosphorylation of ligand-gated channels regu-
lates the channel properties. The accumulated evidence
indicates that phosphatase activity also regulates the sur-
face insertion or cluster of these neuronal receptors. Sev-
eral studies have shown that NMDA-receptor-dependent
LTD is associated with a post-synaptic silence of synapses,
and that a post-synaptic interference with the endocytotic
machinery hampers LTD. A series of studies now show
that the rapid trafficking of AMPA receptors may occur
in the hippocampal or spinal dorsal horn neurons after
subunit phosphorylaiton [74,75]. The internalization of
AMPA receptors can be blocked by inhibitors of protein
phosphotase, indicating that protein phosphatase might
have a regulatory role in LTD [76]. Currently, little is
known about the role of PP2A in the trafficking of AMPA
receptor subunits. It has been demonstrated that a mem-
brane insertion of Ca2+-permeable AMPA receptors great-
ly contributes to the synaptic plasticity in hippocampus
and central sensitization of pain in the spinal cord dorsal
horns [8,77]. Huganir’s group has also shown that the traf-
ficking of AMPA receptors is regulated through the PKA
phosphorylation of GluA1 subunits [78,79]. Another study
indicated that the signaling pathway that drive the inser-
tion of GluA1 subunits into the plasma membrane during
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neurons, intrathecal application of a CaMKII inhibitor,
KN-93, before the painful visceral stimulus, apparently in-
hibits the GluA1 accumulation in the plasma membrane
fraction. Peripheral inflammation stimuli drive the phos-
phorylation and trafficking of AMPA receptor subunits in
spinal cord dorsal horns [81,82]. The data suggests that
the phosphorylation or de-phosphorylation of AMPA re-
ceptors is closely associated with the receptor trafficking
events. The GluA1 subunit is an important substrate of
PP2A, indicating activated PP2A is a critical modulator of
AMPA receptor trafficking and might play an important
role in AMPA receptor-mediated nociception (Figure 2).
In future studies, it will be valuable to determine the activ-
ity status of PP2A in the spinal cord dorsal horns and the
de-sphosphorylation as well as trafficking regulation of
AMPA receptor GluA1 or GluA2 subunits by PP2A in dif-
ferent animal models of pain.
PP2A regulates synaptic transmission through influencing
transcription factors and subsequent chromatin
remodeling
Another way in which phosphatases might regulate syn-
aptic transmission on a longer timescale is through the
alternation of chromatin remodeling and gene transcrip-
tion. Calcium-dependent gene transcription has a critical
role in both synaptic plasticity and memory formation.
The transcription factor cAMP-response-element-bind-
ing protein (CREB) has been demonstrated to be in-
volved in synaptic plasticity and long-term memory, and
serves a substrate for various phosphatases as well [57].
In cultured hippocampal neurons, PP1 and/or PP2A are
observed to be main CREB phosphatases, and although
PP2B does not directly de-phosphorylate CREB, it none-
theless has a key role in regulating CREB-mediated tran-
scription process [83]. Various stimuli evoke the transient
phosphorylation of CREB protein, but a more sustained
phosphorylation seems to be necessary for a CREB-
mediated transcription to occur. It has been shown that
PP2A may play a critical role in constraining the pro-
gression of information from the synapse to the nucleus
(Figure 2). It will be important to learn how the activity
dependent regulation of PP2A influences the relevant
gene expression. PP2A has been shown to form a signal-
ing complex with CaMKIV that regulates CREB phos-
phorylation, and thus, a CREB-mediated transcription
[51]. PP2A holoenzymes may also negatively regulate
NF-κB-mediated transcriptional activities [84]. Some
PP2A regulatory subunits, such as PR55γ and PR55δ,
are inhibitors of JNK and c-Src kinases, which are im-
portant to regulate transcription factors.
The important role for multiple protein kinases in regu-
lation of nociception in animal studies suggests its func-
tion on nociception-elicited gene expression throughmediation of transcription factors, such as c-fos and CREB.
Increased phosphorylation of CREB protein through the
activation of glutamate receptors and the PKA, PKC, and
CaMKII cascades during central sensitization was repor-
ted in several animal models of pain [2,6,10,42]. It suggests
an intra-cellular connection between activation of tran-
scription factors and molecular mechanisms mediating
stimuli-induced nuclear gene activation through several
protein kinase pathways. PP2A may exert a negative ac-
tion on CREB-mediated transcription-dependent central
sensitization, since CREB is an important substrate of
PP2A. Future investigations need to determine the regula-
tion of PP2A activity during central sensitization through
multiple transcription factors, such as c-fos, c-Jun and
NF-κB.
Previous studies have suggested that post-translational
or epi-genetic modification (acetylation, methylation,
phosphorylation, etc.) of histones, and subsequently re-
modeling of chromatin structure, play a critical role in
controlling gene transcription and facilitating long-term
changes during synaptic plasticity and central sensitization
of pain [85-88]. Chromatin structures are regulated in hip-
pocampal and spinal neurons in response to activation of
multiple kinase activation. In particular, it has been shown
that the histone acetyltransferase activity of CREB binding
protein (CBP) is necessary for synaptic plasticity and cen-
tral sensitization of pain [89]. CREB can be phosphory-
lated and activated by different kinases and then it
recruits the histone acetyltransferase co-activator CBP
and its homologue p300. The recruitment of CBP/p300
and changes in the level of histone acetylation are re-
quired for gene transcription. Another study from our
group reported that the activated JNK signaling pathway
was observed to contribute to the regulation of histone
remodeling in peripheral sensory neurons following neu-
rotoxic stimulation [90]. Therefore, PP2A activity may
regulate the histone-acetylation induced subsequent neuro-
epigenetic changes and downstream gene transcription
through the de-phosphorylation of CREB.
In contrast to histone acetylase, histone deacetylase
(HDAC) may remove acetyl groups from lysine residues
of histones, and other non-histone proteins, and reverse
the action of histone acetylase and block the gene tran-
scription process. PP2A comprises a family of holoen-
zyme complexes with diverse biological activities, which
mainly depend on individual regulatory subunits. The
PP2A heterotrimeric complex was formed by the PP2A-
A subunit and the catalytic subunit (PP2A-C), while
G5PR as a regulatory subunit exhibits phosphatase activ-
ity on histone H1. Class II HDACs are key transcrip-
tional regulators whose activities are controlled via
phosphorylation-dependent nucleo-cytoplasmic shuttling
[91]. PP2A is responsible for de-phosphorylation of class
II HDACs triggering nuclear localization and repression
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plasmatic localization leading to activation of target
genes [91] (Figure 2). Recent studies have shown that
the HDACs have been implicated in spinal nociception
in inflammatory pain [92,93]. It is presumable that PP2A
may regulate the gene expression in the spinal cord dor-
sal horns elicited by peripheral noxious stimuli through
the de-phosphorylation of class II HDACs and subse-
quent neuro-epigenetic alternations.
Concluding remark
In this review, we have highlighted the roles of PP2A in
synaptic plasticity and central sensitization of nocicep-
tive process. Specifically, they have key roles in limiting
LTP induction and maintenance, and in triggering LTD
induction. PP2A activity is regulated by holoenzyme
composition, post-translational modification of methyla-
tion and phosphorylation. PP2A may exert its action
through the de-phosphorylaiton of critical substrates
relevant to nociceptive processing, such as NMDA re-
ceptor subunits, AMPA receptor GluA1 subunits, tran-
scription factors and class II HDACs. All these substrate
molecules are implicated in synaptic plasticity and cen-
tral sensitization in the central nervous system. PP2A
may serve as a potential molecular target that can be se-
lectively and effectively modulated through pharmaceut-
ical intervention to treat pain.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
YW participated in the design of the review and drafted the manuscript. YL,
JW and YM assisted with the preparation of the manuscript and figures. LF,
and XZ conceived of the review and participated in its design and helped to
draft the manuscript. All authors read and approved the final manuscript.
Acknowledgments
This work was supported by National Natural Science Foundation of China
(30801073/H0903, 81171055/H0903), Natural Science Foundation of Beijing
(7112054) and New Century Excellent Talents Program from Ministry of
Education, China (NCET-10-0014).
Author details
1Department of Anesthesiology, Beijing Chaoyang Hospital, Capital Medical
University, Beijing 100020, China. 2Department of Neuroscience and Cell
Biology, The University of Texas Medical Branch, Galveston, TX 77555-0517,
USA. 3Department of Neurosurgery, Cancer Center, Sun Yat-sen University,
Guangzhou 510060, China. 4Department of Neurosurgery and Neurology,
Lineberger Cancer Center, School of Medicine, University of North Carolina,
Chapel Hill, NC 27599, USA.
Received: 23 February 2013 Accepted: 30 August 2013
Published: 8 September 2013
References
1. Fang L, Wu J, Lin Q, Willis WD: Calcium-calmodulin-dependent protein
kinase II contributes to spinal cord central sensitization. J Neurosci 2002,
22:4196–4204.
2. Wu J, Su G, Ma L, Zhang X, Lei Y, Li J, Lin Q, Fang L: Protein kinases
mediate increment of the phosphorylation of cyclic AMP-responsive
element binding protein in spinal cord of rats following capsaicin
injection. Mol Pain 2005, 1:26.3. Wu J, Li J, Lin Q, Fang L: Signal transduction in chronic pain. Int Anesthesiol
Clin 2007, 45:73–81.
4. Faure C, Ramos M, Girault JA: Pyk2 cytonuclear localization: mechanisms
and regulation by serine dephosphorylation. Cell Mol Life Sci 2013,
70:137–152.
5. Mizuno K: Signaling mechanisms and functional roles of cofilin
phosphorylation and dephosphorylation. Cell Signal 2013, 25:457–469.
6. Fang L, Wu J, Zhang X, Lin Q, Willis WD: Calcium/calmodulin dependent
protein kinase II regulates the phosphorylation of cyclic AMP-responsive
element-binding protein of spinal cord in rats following noxious
stimulation. Neurosci Lett 2005, 374:1–4.
7. Fang L, Wu J, Lin Q, Willis WD: Protein kinases regulate the
phosphorylation of the GluR1 subunit of AMPA receptors of spinal cord
in rats following noxious stimulation. Brain Res Mol Brain Res 2003,
118:160–165.
8. Wang Y, Wu J, Wu Z, Lin Q, Yue Y, Fang L: Regulation of AMPA receptors
in spinal nociception. Mol Pain 2010, 6:5.
9. Wang Y, Mu X, Wu J, Wu A, Fang L, Li J, Yue Y: Differential roles of
phosphorylated AMPA receptor GluR1 subunits at Serine-831 and Serine-845
sites in spinal cord dorsal horn in a rat model of post-operative pain.
Neurochem Res 2011, 36:170–176.
10. Wu J, Fang L, Lin Q, Willis WD: The role of nitric oxide in the
phosphorylation of cyclic adenosine monophosphate-responsive
element-binding protein in the spinal cord after intradermal injection of
capsaicin. J. Pain 2002, 3:190–198.
11. Zhang X, Wu J, Fang L, Willis WD: The effects of protein phosphatase
inhibitors on the duration of central sensitization of rat dorsal horn
neurons following injection of capsaicin. Mol Pain 2006, 2:23.
12. Zhang X, Wu J, Lei Y, Fang L, Willis WD: Protein phosphatase 2A regulates
central sensitization in the spinal cord of rats following intradermal
injection of capsaicin. Mol Pain 2006, 2:9.
13. Zhang X, Wu J, Lei Y, Fang L, Willis WD: Protein phosphatase modulates the
phosphorylation of spinal cord NMDA receptors in rats following
intradermal injection of capsaicin. Brain Res Mol Brain Res 2005, 138:264–272.
14. Zhang X, Wu J, Fang L, Willis WD: The effects of protein phosphatase
inhibitors on nociceptive behavioral responses of rats following
intradermal injection of capsaicin. Pain 2003, 106:443–451.
15. Gabra BH, Bailey CP, Kelly E, Sanders AV, Henderson G, Smith FL, Dewey WL:
Evidence for an important role of protein phosphatases in the
mechanism of morphine tolerance. Brain Res 2007, 1159:86–93.
16. Zhang Q, Claret FX: Phosphatases: the new brakes for cancer
development? Enzyme Res 2012, 2012:659649.
17. Winder DG, Sweatt JD: Roles of serine/threonine phosphatases in
hippocampal synaptic plasticity. Nat Rev Neurosci 2001, 2:461–474.
18. Janssens V, Goris J: Protein phosphatase 2A: a highly regulated family of
serine/threonine phosphatases implicated in cell growth and signalling.
Biochem J 2001, 353:417–439.
19. Janssens V, Longin S, Goris J: PP2A holoenzyme assembly: in cauda
venenum (the sting is in the tail). Trends Biochem Sci 2008, 33:113–121.
20. Janssens V, Derua R, Zwaenepoel K, Waelkens E, Goris J: Specific regulation
of protein phosphatase 2A PR72/B'' subunits by calpain. Biochem Biophys
Res Commun 2009, 386:676–681.
21. Park JH, Sung HY, Lee JY, Kim HJ, Ahn JH, Jo I: B56alpha subunit of protein
phosphatase 2A mediates retinoic acid-induced decreases in
phosphorylation of endothelial nitric oxide synthase at serine 1179 and
nitric oxide production in bovine aortic endothelial cells. Biochem Biophys
Res Commun 2013, 430:476–481.
22. Zwaenepoel K, Louis JV, Goris J, Janssens V: Diversity in genomic
organisation, developmental regulation and distribution of the murine
PR72/B" subunits of protein phosphatase 2A. BMC. Genomics 2008, 9:393.
23. Ahn JH, Sung JY, McAvoy T, Nishi A, Janssens V, Goris J, Greengard P, Nairn AC: The
B''/PR72 subunit mediates Ca2+−dependent dephosphorylation of DARPP-
32 by protein phosphatase 2A. Proc Natl Acad Sci U S A 2007, 104:9876–9881.
24. Lechward K, Awotunde OS, Swiatek W, Muszynska G: Protein phosphatase
2A: variety of forms and diversity of functions. Acta Biochim Pol 2001,
48:921–933.
25. Cho US, Morrone S, Sablina AA, Arroyo JD, Hahn WC, Xu W: Structural basis
of PP2A inhibition by small t antigen. PLoS Biol 2007, 5:e202.
26. Letourneux C, Rocher G, Porteu F: B56-containing PP2A dephosphorylate
ERK and their activity is controlled by the early gene IEX-1 and ERK.
EMBO J 2006, 25:727–738.
Wang et al. Molecular Pain 2013, 9:46 Page 9 of 10
http://www.molecularpain.com/content/9/1/4627. Chen J, Martin BL, Brautigan DL: Regulation of protein serine-threonine
phosphatase type-2A by tyrosine phosphorylation. Science 1992, 257:1261–1264.
28. Longin S, Zwaenepoel K, Martens E, Louis JV, Rondelez E, Goris J, Janssens V:
Spatial control of protein phosphatase 2A (de)methylation. Exp Cell Res
2008, 314:68–81.
29. Longin S, Zwaenepoel K, Louis JV, Dilworth S, Goris J, Janssens V: Selection
of protein phosphatase 2A regulatory subunits is mediated by the C
terminus of the catalytic Subunit. J Biol Chem 2007, 282:26971–26980.
30. Ogris E, Gibson DM, Pallas DC: Protein phosphatase 2A subunit assembly:
the catalytic subunit carboxy terminus is important for binding cellular B
subunit but not polyomavirus middle tumor antigen. Oncogene 1997,
15:911–917.
31. Bryant JC, Westphal RS, Wadzinski BE: Methylated C-terminal leucine
residue of PP2A catalytic subunit is important for binding of regulatory
Balpha subunit. Biochem J 1999, 339(Pt 2):241–246.
32. Leulliot N, Quevillon-Cheruel S, Sorel I, de La Sierra-Gallay L, Collinet B,
Graille M, Blondeau K, Bettache N, Poupon A, Janin J, van TH: Structure of
protein phosphatase methyltransferase 1 (PPM1), a leucine carboxyl
methyltransferase involved in the regulation of protein phosphatase 2A
activity. J Biol Chem 2004, 279:8351–8358.
33. Rudrabhatla P, Pant HC: Role of protein phosphatase 2A in Alzheimer's
disease. Curr Alzheimer Res 2011, 8:623–632.
34. Torrent L, Ferrer I: PP2A and Alzheimer disease. Curr Alzheimer Res 2012,
9:248–256.
35. Sun XY, Wei YP, Xiong Y, Wang XC, Xie AJ, Wang XL, Yang Y, Wang Q, Lu YM,
Liu R, Wang JZ: Synaptic released zinc promotes tau hyperphosphorylation
by inhibition of protein phosphatase 2A (PP2A). J Biol Chem 2012,
287:11174–11182.
36. Sontag E, Hladik C, Montgomery L, Luangpirom A, Mudrak I, Ogris E, White CL
III: Downregulation of protein phosphatase 2A carboxyl methylation and
methyltransferase may contribute to Alzheimer disease pathogenesis.
J Neuropathol Exp Neurol 2004, 63:1080–1091.
37. Sontag E, Luangpirom A, Hladik C, Mudrak I, Ogris E, Speciale S, White CL III:
Altered expression levels of the protein phosphatase 2A ABalphaC
enzyme are associated with Alzheimer disease pathology. J Neuropathol
Exp Neurol 2004, 63:287–301.
38. Sandkuhler J, Gruber-Schoffnegger D: Hyperalgesia by synaptic long-term
potentiation (LTP): an update. Curr Opin Pharmacol 2012, 12:18–27.
39. Sandkuhler J: Central sensitization versus synaptic long-term potentiation
(LTP): a critical comment. J Pain 2010, 11:798–800.
40. Larsson M, Broman J: Synaptic plasticity and pain: role of ionotropic
glutamate receptors. Neuroscientist 2011, 17:256–273.
41. Larsson M, Broman J: Translocation of GluR1-containing AMPA receptors
to a spinal nociceptive synapse during acute noxious stimulation.
J Neurosci 2008, 28:7084–7090.
42. Wu J, Su G, Ma L, Zhang X, Lei Y, Lin Q, Nauta HJ, Li J, Fang L: The role of
c-AMP-dependent protein kinase in spinal cord and post synaptic dorsal
column neurons in a rat model of visceral pain. Neurochem Int 2007,
50:710–718.
43. Willis WD: Role of neurotransmitters in sensitization of pain responses.
Ann N Y Acad Sci 2001, 933:142–156.
44. Tanabe M, Nagatani Y, Saitoh K, Takasu K, Ono H: Pharmacological
assessments of nitric oxide synthase isoforms and downstream diversity
of NO signaling in the maintenance of thermal and mechanical
hypersensitivity after peripheral nerve injury in mice. Neuropharmacology
2009, 56:702–708.
45. Schmidtko A, Ruth P, Geisslinger G, Tegeder I: Inhibition of cyclic
guanosine 5'-monophosphate-dependent protein kinase I (PKG-I) in
lumbar spinal cord reduces formalin-induced hyperalgesia and PKG
upregulation. Nitric. Oxide. 2003, 8:89–94.
46. Bliss TV, Collingridge GL: A synaptic model of memory: long-term
potentiation in the hippocampus. Nature 1993, 361:31–39.
47. Thiels E, Norman ED, Barrionuevo G, Klann E: Transient and persistent
increases in protein phosphatase activity during long-term depression in
the adult hippocampus in vivo. Neuroscience 1998, 86:1023–1029.
48. Figurov A, Boddeke H, Muller D: Enhancement of AMPA-mediated
synaptic transmission by the protein phosphatase inhibitor calyculin A
in rat hippocampal slices. Eur J Neurosci 1993, 5:1035–1041.
49. Blitzer RD, Wong T, Nouranifar R, Iyengar R, Landau EM: Postsynaptic cAMP
pathway gates early LTP in hippocampal CA1 region. Neuron 1995,
15:1403–1414.50. Winder DG, Mansuy IM, Osman M, Moallem TM, Kandel ER: Genetic and
pharmacological evidence for a novel, intermediate phase of long-term
potentiation suppressed by calcineurin. Cell 1998, 92:25–37.
51. Blitzer RD, Connor JH, Brown GP, Wong T, Shenolikar S, Iyengar R, Landau
EM: Gating of CaMKII by cAMP-regulated protein phosphatase activity
during LTP. Science 1998, 280:1940–1942.
52. Makhinson M, Chotiner JK, Watson JB, O'Dell TJ: Adenylyl cyclase
activation modulates activity-dependent changes in synaptic strength
and Ca2+/calmodulin-dependent kinase II autophosphorylation.
J Neurosci 1999, 19:2500–2510.
53. Fukunaga K, Muller D, Ohmitsu M, Bako E, DePaoli-Roach AA, Miyamoto E:
Decreased protein phosphatase 2A activity in hippocampal long-term
potentiation. J Neurochem 2000, 74:807–817.
54. Strack S, Choi S, Lovinger DM, Colbran RJ: Translocation of
autophosphorylated calcium/calmodulin-dependent protein kinase II to
the postsynaptic density. J Biol Chem 1997, 272:13467–13470.
55. Pi HJ, Lisman JE: Coupled phosphatase and kinase switches produce the
tristability required for long-term potentiation and long-term
depression. J Neurosci 2008, 28:13132–13138.
56. Mulkey RM, Herron CE, Malenka RC: An essential role for protein
phosphatases in hippocampal long-term depression. Science 1993,
261:1051–1055.
57. Mauna JC, Miyamae T, Pulli B, Thiels E: Protein phosphatases 1 and 2A are
both required for long-term depression and associated
dephosphorylation of cAMP response element binding protein in
hippocampal area CA1 in vivo. Hippocampus 2011, 21:1093–1104.
58. Woo NH, Nguyen PV: "Silent" metaplasticity of the late phase of
long-term potentiation requires protein phosphatases. Learn Mem
2002, 9:202–213.
59. Jouvenceau A, Billard JM, Haditsch U, Mansuy IM, Dutar P: Different
phosphatase-dependent mechanisms mediate long-term depression and
depotentiation of long-term potentiation in mouse hippocampal CA1
area. Eur J Neurosci 2003, 18:1279–1285.
60. Tapia R, Pena F, Arias C: Neurotoxic and synaptic effects of okadaic acid,
an inhibitor of protein phosphatases. Neurochem Res 1999, 24:1423–1430.
61. Huang CC, Liang YC, Hsu KS: Characterization of the mechanism underlying
the reversal of long term potentiation by low frequency stimulation at
hippocampal CA1 synapses. J Biol Chem 2001, 276:48108–48117.
62. Arias C, Montiel T, Pena F, Ferrera P, Tapia R: Okadaic acid induces epileptic
seizures and hyperphosphorylation of the NR2B subunit of the NMDA
receptor in rat hippocampus in vivo. Exp Neurol 2002, 177:284–291.
63. Chan SF, Sucher NJ: An NMDA receptor signaling complex with protein
phosphatase 2A. J Neurosci 2001, 21:7985–7992.
64. Atianjoh FE, Yaster M, Zhao X, Takamiya K, Xia J, Gauda EB, Huganir RL, Tao
YX: Spinal cord protein interacting with C kinase 1 is required for the
maintenance of complete Freund's adjuvant-induced inflammatory pain
but not for incision-induced post-operative pain. Pain 2010, 151:226–234.
65. Kristensen AS, Jenkins MA, Banke TG, Schousboe A, Makino Y, Johnson RC,
Huganir R, Traynelis SF: Mechanism of Ca2+/calmodulin-dependent kinase II
regulation of AMPA receptor gating. Nat Neurosci 2011, 14:727–735.
66. Anggono V, Huganir RL: Regulation of AMPA receptor trafficking and
synaptic plasticity. Curr Opin Neurobiol 2012, 22:461–469.
67. Park JS, Voitenko N, Petralia RS, Guan X, Xu JT, Steinberg JP, Takamiya K,
Sotnik A, Kopach O, Huganir RL, Tao YX: Persistent inflammation induces
GluR2 internalization via NMDA receptor-triggered PKC activation in
dorsal horn neurons. J Neurosci 2009, 29:3206–3219.
68. Clem RL, Anggono V, Huganir RL: PICK1 regulates incorporation of
calcium-permeable AMPA receptors during cortical synaptic
strengthening. J Neurosci 2010, 30:6360–6366.
69. Lee HK, Kameyama K, Huganir RL, Bear MF: NMDA induces long-term
synaptic depression and dephosphorylation of the GluR1 subunit of
AMPA receptors in hippocampus. Neuron 1998, 21:1151–1162.
70. Kameyama K, Lee HK, Bear MF, Huganir RL: Involvement of a postsynaptic
protein kinase A substrate in the expression of homosynaptic long-term
depression. Neuron 1998, 21:1163–1175.
71. Larsson M, Broman J: Pathway-specific bidirectional regulation of Ca2
+/calmodulin-dependent protein kinase II at spinal nociceptive synapses
after acute noxious stimulation. J Neurosci 2006, 26:4198–4205.
72. Lee HK, Barbarosie M, Kameyama K, Bear MF, Huganir RL: Regulation of
distinct AMPA receptor phosphorylation sites during bidirectional
synaptic plasticity. Nature 2000, 405:955–959.
Wang et al. Molecular Pain 2013, 9:46 Page 10 of 10
http://www.molecularpain.com/content/9/1/4673. Lee HK, Takamiya K, Han JS, Man H, Kim CH, Rumbaugh G, Yu S, Ding L, He C,
Petralia RS, Wenthold RJ, Gallagher M, Huganir RL: Phosphorylation of the
AMPA receptor GluR1 subunit is required for synaptic plasticity and
retention of spatial memory. Cell 2003, 112:631–643.
74. Lu W, Roche KW: Posttranslational regulation of AMPA receptor
trafficking and function. Curr Opin Neurobiol 2012, 22:470–479.
75. Peng HY, Chen GD, Hsieh MC, Lai CY, Huang YP, Lin TB: Spinal SGK1/
GRASP-1/Rab4 is involved in complete Freund's adjuvant-induced
inflammatory pain via regulating dorsal horn GluR1-containing AMPA
receptor trafficking in rats. Pain 2012, 153:2380–2392.
76. Beattie EC, Carroll RC, Yu X, Morishita W, Yasuda H, von ZM, Malenka RC:
Regulation of AMPA receptor endocytosis by a signaling mechanism
shared with LTD. Nat Neurosci 2000, 3:1291–1300.
77. Clem RL, Huganir RL: Calcium-permeable AMPA receptor dynamics
mediate fear memory erasure. Science 2010, 330:1108–1112.
78. Esteban JA, Shi SH, Wilson C, Nuriya M, Huganir RL, Malinow R: PKA
phosphorylation of AMPA receptor subunits controls synaptic trafficking
underlying plasticity. Nat Neurosci 2003, 6:136–143.
79. Man HY, Sekine-Aizawa Y, Huganir RL: Regulation of {alpha}-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid receptor trafficking through
PKA phosphorylation of the Glu receptor 1 subunit. Proc Natl Acad Sci
USA 2007, 104:3579–3584.
80. Hayashi Y, Shi SH, Esteban JA, Piccini A, Poncer JC, Malinow R: Driving
AMPA receptors into synapses by LTP and CaMKII: requirement for
GluR1 and PDZ domain interaction. Science 2000, 287:2262–2267.
81. Tao YX: AMPA receptor trafficking in inflammation-induced dorsal horn
central sensitization. Neurosci Bull 2012, 28:111–120.
82. Choi JI, Svensson CI, Koehrn FJ, Bhuskute A, Sorkin LS: Peripheral
inflammation induces tumor necrosis factor dependent AMPA receptor
trafficking and Akt phosphorylation in spinal cord in addition to pain
behavior. Pain 2010, 149:243–253.
83. Huang L, Balsara RD, Sheng Z, Castellino FJ: Conantokins inhibit NMDAR-
dependent calcium influx in developing rat hippocampal neurons in
primary culture with resulting effects on CREB phosphorylation. Mol Cell
Neurosci 2010, 45:163–172.
84. Hsieh CY, Hsu MJ, Hsiao G, Wang YH, Huang CW, Chen SW, Jayakumar T,
Chiu PT, Chiu YH, Sheu JR: Andrographolide enhances nuclear factor-
kappaB subunit p65 Ser536 dephosphorylation through activation of
protein phosphatase 2A in vascular smooth muscle cells. J Biol Chem
2011, 286:5942–5955.
85. Denk F, McMahon SB: Chronic pain: emerging evidence for the
involvement of epigenetics. Neuron 2012, 73:435–444.
86. Sultan FA, Day JJ: Epigenetic mechanisms in memory and synaptic
function. Epigenomics 2011, 3:157–181.
87. Geranton SM: Targeting epigenetic mechanisms for pain relief. Curr Opin
Pharmacol 2012, 12:35–41.
88. Wang Y, Chen Z, Zhao Y, Shi R, Wang Y, Xu J, Wu A, Johns RA, Yue Y:
Epigenetics as a new therapeutic target for postoperative cognitive
dysfunction. Med Hypotheses 2013, 80:249–251.
89. Zhu XY, Huang CS, Li Q, Chang RM, Song ZB, Zou WY, Guo QL: p300 exerts
an epigenetic role in chronic neuropathic pain through its
acetyltransferase activity in rats following chronic constriction injury
(CCI). Mol. Pain 2012, 8:84.
90. Wu J, Zhang X, Nauta HJ, Lin Q, Li J, Fang L: JNK1 regulates histone
acetylation in trigeminal neurons following chemical stimulation.
Biochem Biophys Res Commun 2008, 376:781–786.
91. Paroni G, Cernotta N, Dello RC, Gallinari P, Pallaoro M, Foti C, Talamo F,
Orsatti L, Steinkuhler C, Brancolini C: PP2A regulates HDAC4 nuclear
import. Mol Biol Cell 2008, 19:655–667.
92. Tochiki KK, Cunningham J, Hunt SP, Geranton SM: The expression of spinal
methyl-CpG-binding protein 2, DNA methyltransferases and histone
deacetylases is modulated in persistent pain states. Mol. Pain 2012, 8:14.
93. Zhang Z, Cai YQ, Zou F, Bie B, Pan ZZ: Epigenetic suppression of GAD65
expression mediates persistent pain. Nat Med 2011, 17:1448–1455.
doi:10.1186/1744-8069-9-46
Cite this article as: Wang et al.: Roles of phosphotase 2A in nociceptive
signal processing. Molecular Pain 2013 9:46.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
